LITTLE FALLS, N.J.,
March 2, 2015 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) announced today
that Andrew A. Krakauer, CEO, will
be presenting at the Sidoti & Company 19th Annual Emerging
Growth Institutional Investor Forum. The formal presentation is
scheduled for 2:00 PM ET on
Monday, March 16, 2015 at the Grand
Hyatt Hotel, New York. In
addition, Mr. Krakauer, and Seth
Yellin, Senior VP-Corporate Development, will be available
for separate one-on-one meetings during the day.
About Cantel Medical
Corp.
Cantel Medical is a leading global company dedicated to delivering
innovative infection prevention and control products and services
for patients, caregivers, and other healthcare providers which
improve outcomes, enhance safety and help save lives. Our
products include specialized medical device reprocessing systems
for endoscopy and renal dialysis, advanced water purification
equipment, sterilants, disinfectants and cleaners, sterility
assurance monitoring products for hospitals and dental clinics,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates, hollow fiber membrane
filtration and separation products, and specialty packaging for
infectious and biological specimens. Additionally, we provide
technical service for our products. For further information,
visit the Cantel website at www.cantelmedical.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-present-at-the-sidoti--company-19th-annual-emerging-growth-institutional-investor-forum-300043181.html
SOURCE Cantel Medical Corp.